Objectives-Ultrasound serves an important role in the prenatal diagnosis of fetal structural anomalies. Recently, there has been increased use of teleultrasound protocols. We aimed to evaluate the sensitivity and accuracy of teleultrasound.
T he anatomic survey is an important aspect of prenatal care. Screening ultrasound examinations are critical for identifying anomalous fetuses who need to be delivered at tertiary care centers, as well as other aspects of prenatal care, including decisions about pregnancy continuation, genetic testing, and medical management.
Over the past 2 decades, interest in developing teleultrasound protocols has increased. Teleultrasound allows patients located in rural or resource-scarce areas to benefit from the expertise of a subspecialist who can view and interpret the ultrasound images from another location, often from great distances. 1, 2 Initially, the feasibility of teleultrasound was limited by the technology required to transmit highquality ultrasound images in an efficient format [3] [4] [5] ; however, now the focus is on expanding the use and accuracy of teleultrasound, as well as improving the patient experience. 6, 7 Supplemental material online at jultrasoundmed.org
There are scarce data regarding the sensitivity and accuracy of teleultrasound. 8, 9 There is no standard detection rate for the reference study (on-site ultrasound) and often no robust method of validation (ie, postnatal diagnosis). A large systematic review of 36 studies noted overall sensitivity of 40.4%, with a range of 13.3% to 82.4% 10 for identifying structural anomalies. Arkansas is an ideal state in which to use teleultrasound and, as such, has been doing so for more than a decade. 11, 12 Primarily a rural state, 73 of the 75 counties in Arkansas are designated as medically underserved. Nineteen percent of the population is considered impoverished, and 49% of all pregnancies are paid for by Medicaid. [13] [14] [15] Arkansas established the Antenatal and Neonatal Guidelines, Education, and Learning System Program, 12 which consists of a network of providers and infrastructure throughout the state that provides telemedicine services (including ultrasound) to all obstetric patients. There is also the Arkansas Reproductive Health Monitoring System (ARHMS), which conducts active surveillance of birth defects for the entire state. Using these data sources, we sought to determine the validity of teleultrasound. We anticipated that teleultrasound would have sensitivity of at least 40% and accuracy of greater than 90%. In addition, as a secondary outcome, we evaluated the number of ultrasound examinations required to complete a targeted anatomic survey.
Materials and Methods
We conducted a retrospective cohort study approved by the Institutional Review Board of the University of Arkansas for Medical Sciences (UAMS; Institutional Review Board number 136448). All targeted ultrasound examinations performed via telemedicine were considered for this protocol. Ultrasound examinations were excluded if they were performed before 16 completed weeks' gestation, if there was a multiple gestation, or if the examination was performed for any reason other than an anatomic survey (eg, follow-up growth and Doppler evaluation). Teleultrasound referrals were for abnormal serum screening results, abnormal ultrasound findings at an outside facility, a prior affected child or family history (eg, birth defect, syndrome, or aneuploidy), and medical comorbidity (eg, obesity, diabetes, lupus, or isoimmunization).
Ultrasound Examination Quality
Ultrasound examinations were performed by a team of 6 sonographers at 28 sites around Arkansas. All sonographers are registered diagnostic medical sonographers who underwent an orientation at the UAMS Prenatal Genetics Clinic to ensure consistency in ultrasound examination performance. In addition, there is continuous quality control with additional supervision and training when indicated. Teleultrasound is conducted in either a "store-and-forward" method with still images and cine clips or with real-time transmission and viewing of high-definition video. All ultrasound examinations are interpreted by 1 of 4 board-certified maternalfetal medicine physicians who are immediately available for interpretation and counseling. All ultrasound examinations were read within 24 hours of being performed. All teleultrasound sites are connected to the UAMS Prenatal Genetics Clinic and UAMS Hospital via broadband connections, allowing the simultaneous viewing of a high-definition ultrasound examination and up to 4 other connections (eg, genetic counselor, interpreter, and patient). The ultrasound examinations were viewed and interpreted on Viewpoint 6 software (Viewpoint, Solingen, Germany).
Cohort Creation
To create the cohort, we matched the timing of the ultrasound examinations with the expected range of delivery dates. In November 2010, the UAMS converted to a new ultrasound reporting software package; therefore, the earliest ultrasound reports available were from November 2010. The most recent available birth outcome data were through December 2012. Eligibility for the ARHMS includes live births with an initial diagnosis of a major birth defect up to 2 years of age, stillbirths of at least 20 weeks' gestation, early fetal losses, and elective terminations at any gestational age. Therefore, we included all ultrasound reports from November 2010 through August 2012 and all birth outcome data from November 2010 through December 2012.
Data Extraction
We manually reviewed each ultrasound report and extracted the following data: demographic information, gestational age, all fetal structural anomalies and soft markers, the amniotic fluid volume status, and the number of ultrasound examinations required to complete the anatomic survey. Placental, uterine, and maternal abnormalities were not extracted (eg, previa, accreta, and fibroids). Supplemental Table S1 lists the categories and specific fetal anomalies. This list is based on the official list of defects monitored by the ARHMS, which are coded by using the British Pediatric Association extension of the International Classification of Diseases, Ninth Edition Clinical Modification coding system, as modified by the Division of Birth Defects and Developmental Disabilities of the Centers for Disease Control and Prevention and the ARHMS.
A computer algorithm was used to find matches between the teleultrasound database and the ARHMS database. The algorithm was based on the maternal first name, last name, and maternal date of birth. Every match was manually checked by the ultrasound date, estimated neonatal delivery date, and infant birth defect. This process allowed us to capture any patients whose last name may have changed while ensuring an efficient process for matching prenatal with postnatal diagnoses.
Statistical Analyses
All statistical analyses were performed by S.O. using SAS version 9.4 software (SAS Institute Inc, Cary, NC). Descriptive statistics for continuous variables are expressed as mean 6 standard deviation or median (interquartile range), where appropriate. The characteristics of the diagnostic test, including the congenital anomaly prevalence, accuracy, sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value, all with their respective 95% confidence intervals (CIs) for identifying congenital anomalies with teleultrasound, were calculated. The reference standard was defined as the presence or absence of a congenital anomaly(ies) at birth as identified by the ARHMS. The level of agreement in identifying a congenital anomaly(ies) by teleultrasound with the presence or absence of an anomaly(ies) at birth was measured by the Cohen j statistic, with levels of agreement characterized by Landis and Koch 16 
Results
There were 2499 ultrasound examinations performed during the study period, and 2368 met the inclusion criteria. The excluded studies consisted of 112 multiple gestations, 8 ultrasound examinations performed before 17 weeks, 3 duplicate studies, and 8 ultrasound examinations that were performed for reasons other than an anatomic evaluation. During the study period, 79,183 births occurred statewide, with 2234 infants noted to have birth defects, for an overall prevalence rate of 2.82%. Both of these figures included stillbirths and terminations. Demographic data for the teleultrasound population are listed in Table 1 . Basic diagnostic statistics of the study population are noted in Table 2 . Overall, our cohort had a congenital anomaly prevalence rate of 5.66% (95% CI, 4.76%-6.67%). The agreement level between teleultrasound and anomalies identified by the ARHMS was moderate (j 5 0.59; 95% CI, 0.52-0.67). The total accuracy, which was the proportion of truepositive results that correctly identified the specific anomaly (not just the presence of an anomaly), was 95.9%. The sensitivity of anomaly detection by teleultrasound was 57.46% (95% CI, 48.63%-65.96%), whereas the specificity was 98.21% (95% CI, 97.57%-98.72%).
Ventricular septal defects are among the most common congenital anomalies and are also among the most commonly missed congenital anomalies. 17 Therefore, we recalculated the diagnostic statistics above after excluding ventricular septal defects. The agreement level was substantial (j 5 0.63); the accuracy and sensitivity increased to 96.7% and 66.96%, respectively; whereas the specificity remained unchanged (98.22%). Data are presented as mean 6 SD and median (interquartile range). Table 3 displays the false-positive and false-negative frequencies by category. False-positive results refer to those anomalies detected on prenatal ultrasound examinations but not present at birth, whereas false-negative results refer to those anomalies present at birth but not detected prenatally. We excluded certain anomalies from the false-negative calculation. For example, we excluded a patent ductus arteriosus and patent foramen ovale because they are not prenatal fetal anomalies. We also excluded atrial septal defects because these have a very low prenatal detection rate. 17 Congenital hypertrophic pyloric stenosis, anal atresia, and hypospadias were also excluded because it is exceedingly uncommon to diagnose these prenatally. 18, 19 Finally, all of the true-positive results (instances in which an anomaly was detected prenatally and was present at birth) were compared to assess agreement between the prenatal and postnatal diagnoses. If the category and medical management of the prenatal diagnosis were the same as those of the postnatal diagnosis, the diagnosis was considered correct. For example, a prenatal diagnosis of a complex heart defect that was postnatally diagnosed as transposition of the great vessels was considered a correct diagnosis. Similarly, a third-trimester prenatal diagnosis of bilateral renal agenesis that was postnatally noted to be atrophied bilateral multicystic dysplastic kidneys was considered correct. There was 98.6% agreement among the truepositive results. The single disagreement was a prenatal diagnosis of a unilateral multicystic kidney and a postnatal diagnosis of a complex heart defect (atrial septal aneurysm).
We also analyzed the rates of completion of anatomic surveys after 1, 2, or 3 ultrasound examinations, as well as the number of patients whose anatomy was not completely evaluated. Since accurate dating is dependent on an ultrasound examination before 22 weeks' gestation, we also evaluated the anatomic survey completion rates as a subset of the population whose first ultrasound examination was performed before 22 weeks. These date are shown in Table 4 . Of note, the denominator for the second and third ultrasound completion rates is the number of patients who had a second or third ultrasound examination. A large percentage of patients did not return for their recommended follow-up ultrasound examinations; these data are also presented in Table 4 .
Discussion
Teleultrasound is a growing subspecialty of telemedicine. In the first and second trimesters of pregnancy, studies have documented fetal echocardiography using spatiotemporal image correlation volumes at 11 weeks to 13 weeks 6 days at a remote site by a generalist obstetrician, with transmission of the images via telemedicine, recognition of most of the structures and views, the use of 4-dimensional sonography between 11 and 15 weeks, and accurate interpretation at sites with expertise in interpreting 4-dimensional echocardiograms. 20, 21 In Arkansas, the number of patients undergoing teleultrasound examinations increases every year. 11, [22] [23] [24] Despite the popularity of teleultrasound, its sensitivity and accuracy for detecting fetal anomalies are unknown, partly because of the lack of a reference value and validation tool to assess these factors.
Our study population had a 5.66% prevalence of congenital anomalies, which was substantially higher than prevalence in the general population of 2.8%. This finding was not unexpected, since our cohort represented a high-risk population: due to either specific conditions (eg, pregestational diabetes, obesity, and advanced maternal age) or the known presence of a fetal anomaly on a prior screening ultrasound examination. We found sensitivity of 57.46% and specificity of 98.21%, both of which are consistent with the literature for on-site prenatal ultrasound.
Among our false-positive results were anencephaly, gastroschisis, bilateral multicystic dysplastic kidneys, and hydrops. On further examination, those fetuses affected with anencephaly, gastroschisis, and hydrops were delivered out of state. Arkansas residency is a requirement for inclusion in the ARHMS database; therefore, we could not confirm the presence of these anomalies at birth, and they appeared as false-positive results in our data set. The prenatal code for bilateral multicystic dysplastic kidneys was given to a patient whose fetus had bilateral echogenic kidneys but otherwise were without cystic changes. Therefore, it is reasonable to assume that there was no congenital renal anomaly at birth. Many other false-positive results are suspected prenatally and either resolve in utero or are not found at birth, including an isolated ventricular septal defect, mild ventriculomegaly, unilateral cystic kidney disease, urinary tract dilatation, and clubfoot.
The false-negative results, or missed diagnoses, represent the limitations of prenatal diagnosis that are well documented in the literature. In our study, specific missed anomalies included a Chiari malformation (without a neural tube defect), 42 congenital heart defects (of which there were 19 ventricular septal defects and 8 atrial septal defects), urinary tract dilatation, pelvic kidney, cleft lip and/or palate, and clubfoot. These were all present at birth, as documented in the AHRMS registry, but were not noted on the prenatal ultrasound examinations. Importantly, none of the missed noncardiac anomalies would have affected management in the immediate neonatal period, which is an important clinical factor. Among the cardiac anomalies that were missed, most were ventricular septal defects and atrial septal defects. The timing of repair of these defects is highly variable depending on the severity of the lesion, and the severity was not indicated in the registry. Therefore, it is not possible to determine whether missing these diagnoses affected immediate neonatal management, although it is unlikely, since most missed ventricular septal defects and atrial septal defects are small and do not require immediate intervention. The remaining cardiac lesions that were missed included a variety of complex anomalies (eg, tetralogy of Fallot, truncus arteriosus, and an atrioventricular canal defect) that required repair in the first year of life but not in the immediate neonatal period.
We were able to complete anatomic surveys in 82% of patients after 1 visit and in 87% of patients after 3 visits. Surprisingly, these rates did not differ when patients were separated by those whose first anatomic survey was before 22 weeks' gestation versus those whose first anatomic survey was after 22 weeks' gestation.
One of the strengths of our study was its uniqueness. To our knowledge, there are scant data investigating the accuracy of teleultrasound. Our sonographers are trained to the same standard as those in the on-site prenatal genetics center. This factor is important because remote interpretation is completely dependent on the quality of the images. Another strength of our study was the availability of a near "reference standard" for birth outcomes. The actual reference standard, autopsy, is only useful for pregnancies that end in terminations, miscarriages, or fetal death. For live births, a statewide population-based birth defect surveillance system that uses active ascertainment methods is a reasonable reference standard for comparison with fetal ultrasound findings. In addition, the ARHMS database abstractors maintain internal validation by assessing multiple sources to ascertain their information (eg, ultrasound reports, medical records, and birth certificate data). Finally, this study was based on an ongoing active teleultrasound program, which makes the information practical and generalizable. There were limitations to our study as well. The study was retrospective in nature; therefore occasionally, ultrasound reports were ambiguous and difficult to extract data from. In addition, whereas we had data from a few thousand studies, a larger cohort would make the study stronger. Unfortunately, the overlap between the ultrasound data and the birth defect registry only allowed for 2 years of data analysis. In addition, some anomalies, such as duodenal atresia, are not evident until the third trimester. If the anatomic survey was complete at the initial ultrasound examination, a follow-up ultrasound examination would not have been indicated. However, this limitation in detection is a limitation of prenatal ultrasound in general and not specific to teleultrasound. Finally, there is the argument that teleultrasound is no different than on-site ultrasound because the reading physician interprets the images on his or her computer regardless of where they were obtained. However, in many centers, including ours, the reading physician performs some degree of hands-on scanning, which could not be done via teleultrasound.
Teleultrasound is a convenient, potentially costeffective solution for patients living in remote or underserved areas. 1, 3 Our study demonstrates that teleultrasound has similar rates of sensitivity and accuracy as published data on on-site ultrasound. This finding is especially reassuring because in a rural area, the on-site ultrasound examinations are likely not of the same quality as those performed at a tertiary care center. Future research is planned to demonstrate that teleultrasound is not inferior to on-site ultrasound within the same population, as well as to conduct a prospective comparison of the detection rates of teleultrasound and on-site ultrasound.
